To analyze whether low expression of 53BP1 and DNA-PKcs correlates with tumor progression/recurrence in patients with non-seminoma GCTs, we performed in silico analyses using a public RNAseq database (see Material and Methods). The gene discussed is PRKDC; the disease is seminoma.